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Abstract
Background: Viruses are obligate intracellular parasites that rely upon the host cell for different
steps in their life cycles. The characterization of cellular genes required for virus infection and/or
cell killing will be essential for understanding viral life cycles, and may provide cellular targets for
new antiviral therapies.
Results: Candidate genes required for lytic reovirus infection were identified by tagged sequence
mutagenesis, a process that permits rapid identification of genes disrupted by gene entrapment.
One hundred fifty-one reovirus resistant clones were selected from cell libraries containing 2 × 105
independently disrupted genes, of which 111 contained mutations in previously characterized genes
and functionally anonymous transcription units. Collectively, the genes associated with reovirus
resistance differed from genes targeted by random gene entrapment in that known mutational hot
spots were under represented, and a number of mutations appeared to cluster around specific
cellular processes, including: IGF-II expression/signalling, vesicular transport/cytoskeletal trafficking
and apoptosis. Notably, several of the genes have been directly implicated in the replication of
reovirus and other viruses at different steps in the viral lifecycle.
Conclusions: Tagged sequence mutagenesis provides a rapid, genome-wide strategy to identify
candidate cellular genes required for virus infection. The candidate genes provide a starting point
for mechanistic studies of cellular processes that participate in the virus lifecycle and may provide
targets for novel anti-viral therapies.
Background
Cellular genes are likely to participate in all phases of viral
life cycles including attachment to cellular receptors,
internalization, disassembly, translation of mRNA,
assembly and egress from the cells [1]. The susceptibility
to virus infection varies greatly among different cell types,
and virus-resistant cells frequently emerge post-infection
[2-4]. This suggests that genetic determinants can influ-
ence host cell contributions to the virus life cycle. Despite
examples of mammalian genes that influence virus infec-
tion, the identification of such genes has been hampered
by the lack of practical methods for genetic analysis in cul-
tured cells. In the present study, we tested whether tagged
sequence mutagenesis – a gene entrapment strategy
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widely used to mutate genes in mouse embryonic stem
cells [5-10] could be used to identify candidate cellular
genes required for lytic infection by reovirus, a small cyto-
lytic RNA virus that replicates in the cytoplasm. The mam-
malian reoviruses serve as useful models for virus-host cell
interaction due to their capacity to replicate preferentially
in proliferating and undifferentiated cells [3].
Gene traps are efficient mutagens as assessed by studies in
mice of mutations induced originally in embryonic stem
cells. In somatic cells, the approach assumes that loss-of-
function mutations induced by gene entrapment may
confer reovirus resistance as a result of gene dosage effects
(e.g. haploinsufficiency), pre-existing heterozygosity or
loss of heterozygosity. Following infection with the
U3NeoSV1 retrovirus gene trap shuttle vector, libraries of
mutagenized rat intestinal epithelial (RIE)-1 cell clones
were isolated in which each clone contained a single gene
disrupted by provirus integration [6]. The entrapment
libraries were infected with reovirus type 1, and virus-
resistant clones were selected under conditions that also
selected against the emergence of persistently infected
cells (PI) that may express virus resistance in the absence
of cellular mutations [4]. Genes disrupted in a total of 151
reovirus resistant cells were identified by sequencing
regions of genomic DNA adjacent to the entrapment vec-
tor [6]; of these, 111 contained mutations in previously
characterized genes and anonymous transcription units.
Reovirus-resistant clones were selected at higher frequen-
cies from entrapment libraries than from non-muta-
genized cells, suggesting that reovirus-resistant
phenotypes were induced by gene trap mutagenesis. How-
ever in any genetic screen, clones with the selected pheno-
type may arise from spontaneous mutations, and
consequently, additional experiments are required to
demonstrate that individual genes disrupted by gene
entrapment actually contribute to the reovirus-resistant
phenotype. For example, a mutation in Ctcf mutation, a
transcriptional repressor of insulin growth factor II (IGF-
II), was one of 4 mutations associated with reovirus resist-
ance that affected IGF-II expression and/or signalling.
Subsequent experiments demonstrated that enforced IGF-
II expression is sufficient to confer high levels of reovirus
resistance [4]. In short, genes collectively identified by
tagged sequence mutagenesis in a panel of reovirus resist-
ant clones provide candidates for mechanistic studies of
cellular processes that participate in the virus lifecycle.
Since the disrupted genes do not adversely affect cell sur-
vival, drugs that inhibit proteins encoded by the genes are
not expected to be overtly toxic to cells. Hence, the candi-
date genes may also include targets for novel anti-viral
therapies.
Results
Tagged sequence mutagenesis and selection of reovirus 
resistant clones
Twenty libraries of mutagenized RIE-1 cells, each repre-
senting approximately 104 independent gene trap events,
were isolated following infection with the U3NeoSV1
gene trap retrovirus. U3NeoSV1 contains coding
sequences for a neomycin resistance gene in the U3 region
of the viral long terminal repeat (LTR). Selection for neo-
mycin resistance generates clones with proviruses inserted
within actively transcribed genes. Cells pooled from each
entrapment library were separately infected with Type 1
reovirus at a multiplicity of infection of 35, and reovirus-
resistant clones were selected in serum-free media to sup-
press the emergence of persistently infected (PI) cells (4).
A total of 151 reovirus-resistant clones were isolated –
approximately 1 mutant per 103 gene trap clones or 1
mutant per 107 reovirus infected cells. For comparison,
the frequency of recovering resistant clones from RIE-1
cells not mutagenized by gene entrapment was less than
10-8. This suggests that reovirus-resistant phenotypes were
induced by gene trap mutagenesis.
Reovirus-resistant cells selected in serum-free media did
not express viral antigens (Figure 1) and did not produce
infectious virus as assessed by plaque assay (E.L. Organ,
unpublished results). Most clones were resistant to infec-
tion by high titre reovirus and were further analyzed (Fig-
ure 2). While reovirus resistance did not initially result
from the establishment of a persistent infection, many
clones became persistently infected upon subsequent pas-
sages, presumably because mutant cells that display virus
resistance are susceptible to the establishment of a PI state
[2] from residual virus used in selection.
Identification of genes disrupted in reovirus-resistant 
clones
The U3NeoSV1 gene trap vector contains a plasmid origin
of replication and ampicillin resistance gene; thus, regions
of genomic DNA adjacent to the targeting vector were
readily cloned by plasmid rescue and sequenced [6]. The
flanking sequences were compared to the nucleic acid
databases to identify candidate cellular genes that confer
resistance to lytic infection by reovirus when altered by
gene entrapment. Altogether, the 151 cloned flanking
sequences matched 111 annotated gene and transcription
units in the public DNA sequence databases [non-redun-
dant (nr), high-throughput genomic sequences (htgs),
and human, mouse, and rat genome sequences [6]. 40
flanking sequences were uninformative because they
matched repetitive elements or regions of genomic DNA
not associated with any annotated transcription unit.
The Supplementary Table [see Additional File 1] lists
genes disrupted in reovirus resistant clones for whichBMC Cell Biology 2004, 5:41 http://www.biomedcentral.com/1471-2121/5/41
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some functional information is available. Many of these
genes encode proteins that are known to physically inter-
act. Genes associated with particular metabolic or signal-
ling pathways are shown in Table 1. These include gene
products that could play potential roles in all aspects of
virus replication: entry, disassembly, transcription, trans-
lation, and reassembly (Table 1, Figure 3, Supplementary
Table [see Additional File 1]). Eleven genes encoding cal-
cyclin, insulin growth factor binding protein 5 protease
(prss11), type C-like lectin protein (Clr)-f and -C, Dnaja1-
/Aprataxin+ (Aprx), GATA binding protein 4 (Gata4), Bcl2
like-1 (Bcl2l1); and chromosome 10 open reading frame 3
(Chr10orf3) and myoferlin, fer-1 like protein 3 (Fer1l3),
S100a6 (encoding calcyclin), and two functionally anon-
ymous cDNAs were independently mutated in separate
cell libraries (Supplementary Table [see Additional File
1]). The proviruses in these independent of mutant clones
were located within 7 to over 1500 nucleotides of each
other (data not shown).
While the presence of multiple, independent mutations in
specific genes provides indirect evidence for their involve-
ment in the reovirus lifecycle, the genes could also repre-
sent hot spots for gene entrapment. The U3NeoSV1 vector
preferentially targets genes with 5' exons that can splice in-
frame with a cryptic splice site in the Neo gene to produce
enzymatically active Neo fusion proteins. As a conse-
quence, mutagenesis by U3NeoSV1 is actually quite
biased, such that of 400 mutations characterized in ES
cells, one-third involved genes disrupted multiple times,
including Pecam1 which was targeted 9 times [11]. How-
ever, none of the multiply targeted genes associated with
Characterization of phenotypic properties of cloned RIE-1  cells resistant to reovirus type 1 infection Figure 1
Characterization of phenotypic properties of cloned 
RIE-1 cells resistant to reovirus type 1 infection (A) 
Cells were stained for reovirus antigen as previously 
described [3]. Only the PI cells contain reovirus antigen as 
detected by immunohistochemistry (dark wells). Upper wells 
contain cloned mutant RIE-1 cells from two sets of RIE-1 
mutant cell lines selected for reovirus resistance. The lower 
wells contain PI RIE-1 (left) and uninfected wild type RIE-1 
(right). (B) Reovirus susceptible L-cell monolayers, main-
tained in 1 ml of completed medium, were used to detect the 
presence of virus in a 100 µl lysate obtained of mutant cells 
(upper two wells), PI RIE-1 cells (lower left) or uninfected 
parental RIE-1 cells (lower right). Note, that only L-cell mon-
olayers exposed to a lysate from PI RIE-1 cells lysed within 
one week of exposure (gentian violet stain).
RIE-1 mutant cells resist lytic infection by reovirus Figure 2
RIE-1 mutant cells resist lytic infection by reovirus 
The columns contain an unselected RIE-1 cell library, RIE-1 
40C, and representative reovirus resistant mutant cell 
clones. Serial two-fold dilutions of reovirus were made with 
the highest titer in the upper row, MOI = 1 × 104. Resistance 
to reovirus type 1 infection was observed in the mutant cells 
3 to 7 days post-infection. The bottom row of cells, denoted 
by "C", were not infected to serve as controls for cell viabil-
ity and proliferation. Cells were stained with gentian violet 
four days post-infection. A clear well indicates cell death fol-
lowing virus infection.BMC Cell Biology 2004, 5:41 http://www.biomedcentral.com/1471-2121/5/41
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reovirus resistance involved previously observed
entrapment hotspots. Conversely, over 10% of the muta-
tions identified in ES cells involved genes for RNA binding
proteins, a preference not observed among genes collec-
tively associated with reovirus resistance. Only Madh7 and
Gas5, each represented once among the reovirus-resistant
clones, were disrupted by U3NeoSV1 in ES cells. Both
genes are commonly targeted by other retroviral gene trap
vectors and thus probably represent hot spots for gene
entrapment [5,8].
Potential involvement of disrupted genes in virus 
replication
The genes associated with reovirus resistance can be
grouped according to their presumed role in virus entry,
disassembly, translation, and maturation. Reovirus enters
the host via an endocytic pathway that requires acidifica-
tion and proteolysis to remove the viral outer capsid. The
presumptive roles of several candidate genes would be
anticipated to affect virus replication by interfering with
virus disassembly. For example the mannose-6-phosphate
receptor/insulin-growth factor-2 receptor (Igf2r) trans-
ports cathepsins to the lysosome [12] and acidification of
the lysosome is dependent upon the vacuolar H+-ATPase
(Atp6v0c) [13]. NH4Cl is a weak base that interferes with
the function of two of the tagged genes, the Igf2r and the
Atp6v0c, and blocks the disassembly of reovirus and sev-
eral other viruses that enter cells via the endocytic path-
way. Moreover, specific inhibitors of the vacuolar H+-
ATPase gene product have been used to block the infectiv-
ity of reovirus and influenza A virus [13,14]. Four muta-
tions in three different genes [Igf2r,  Prss11, a protease
associated with insulin binding protein 5, and Ctcf a tran-
scriptional repressor of IGF-II] are predicted to affect IGF-
II expression and/or signalling. Cells containing the Ctcf
mutation were subsequently found to express elevated
levels IGF-II, while enforced IGF-II expression was suffi-
cient to confer high levels of reovirus resistance. The resist-
ance was caused, at least in part, by a block in virus
disassembly [4]. Similarly, both anti-IGF-II receptor anti-
bodies and soluble IGF-II receptor have been reported to
inhibit herpes simplex virus infection in vitro [15]. By
inference, the recovery of several clones with mutations in
genes involved in IGF-II expression/signalling pathway
suggests that mutations in multiple genes may affect the
same phenotype by acting on a common pathway.
Table 1: Classification of trapped genes according to function Trapped genes are listed by the official HUGO Gene Nomenclature 
Committee names, when available. Functional placement of genes or their products are determined by literature assignments. Some 
genes perform more than one cellular role, and are classified arbitrarily and others have undefined roles.
Transcription Cytoskeletal-Related Membrane Signalling Vesicle/Trafficking
Brd2 Anx3 Abca4 E2ip2 Anxa1
Brd3 Cald1 Celsr2 Fkbp8 Anxa2
Ctcf Calm2 Csmd2 Fusip1 Atp6v0c
E2f2 Kif13b Erbb2ip Gata4 Copg2
Gtf2e1 Mapt OL16 Grb2 Golga2
Hnrpl Ppm1a Pgy1 Jak1 Hm13
Hoxc13 Rps18 Rab13 Madh7 Igf2r
Hp1-bp74 Stmn1 Serp1 Map3k7ip1 Psa
Id3 Tpm1 Pde4b Rabl3
Zfp7 Rraga Rin2
Znf207 Ryk S100a6
Translation Apoptosis Metabolism Chaperonin Ubiquination/
Proteosome
Cstf2 Bcl2l Gas5 Dnaja1 Psma7




Aptx Hspc135 Ocil Wdr5
Clr-f Klhl6 Ror1
Dlx2 Mox2r Scmh1
Dre1 Numb Trim52BMC Cell Biology 2004, 5:41 http://www.biomedcentral.com/1471-2121/5/41
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Additionally, several of the inserted mutations encode
proteins that are thought to participate in trafficking of
cargo in cells, and may participate in various stages of
virus infection. These include mutations in genes
A model of the life cycle of reovirus: proposed checkpoints based on function of the cellular genes identified by the insertional  mutagenesis Figure 3
A model of the life cycle of reovirus: proposed checkpoints based on function of the cellular genes identified by 
the insertional mutagenesis The virus life cycle begins (top, clockwise) with virus binding to cell surface receptor and being 
endocytosed into early endosomes. These endosomes then associate with annexin-II (Anxa2) [62] and fuse with annexin-II-
associated vesicles containing newly synthesized lysosomal enzymes migrating from the Golgi [63], which further fuse with the 
lysosome. The vacuolar H+-ATPase (Atp6v0c) acidifies the lysosome, allowing acid-dependent proteases to digest the outer 
coat from the virus particles and activate them [64]. These activated particles then pass through the lysosomal membrane and 
begin transcription of mRNA. The Golgi protein gm 130 (Golga2) is believed to mediate the docking of vesicles as they carry 
their newly synthesized cargo through the Golgi stack [65, 66]. N-acetylglucosaminyl transferase I (Mgat1) initiates the glyco-
sylation of cell surface proteins (receptors?) and may play a major role, through kinship recognition, in helping maintain the 
correct assortment of lysosomal enzymes [67-71]. The Igf2r shuttles enzymes bound for the lysosome from the Golgi [72] and 
transfer Igf2 to the lysosome. While the roles of calcyclin and the α-tropomyosin (Tpm1) are still unclear, they specifically bind 
each other, and calcyclin is known to bind Anxa2 [16, 20]. Thus, they may be involved in endosome fusion. Eif3s10 specifically 
binds the virus message to begin its preferential translation. The DnaJa1 protein may facilitate the proper folding of virus pro-
teins with its chaperone function [73]. However, DnaJa1 protein and Eif3 may play additional roles in virus trafficking or apop-
tosis, respectively. Eventually, morphogenesis is complete when crystalline-like arrays of new virions form, cell lysis occurs, and 
virus is released. Many of the cellular proteins encoded by mutated genes have direct or indirect roles in trafficking of endo-
somes or lysosomal fusion and thus may play roles in the early disassembly or delivery of transcriptionally active virions to the 
appropriate cell location.BMC Cell Biology 2004, 5:41 http://www.biomedcentral.com/1471-2121/5/41
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encoding three annexins (Anxa1, Anxa2, Anxa3) and cal-
cyclin (S100a6/S100a1) – proteins that may bind to each
other [16-18] – and mutations affecting cytoskeletal and
cytoskeletal associated proteins (Cald1, Kif13b, Mapt,
Mkln1, Stmn1, Tm9sf4, and Tpm1). Annexin-II associates
with cytomegalovirus virions and anti-annexin-II anti-
bodies have been found to prevent cytomegalovirus
plaque formation [19]. Annexin-II is known to bind to
several of the other gene products mutated in our library.
These include annexin-I, calcyclin, and α-tropomysin
(Supplementary Table [see Additional File 1]) [17,18,20].
One of the clones has a disruption of a novel cell receptor,
OL-16, which is a member of the immunoglobulin super-
family [21,22]. A presumptive cellular receptor for reovi-
rus, junctional adhesion molecule (Jam)-1 [22], has been
shown to bind to all reovirus serotypes [23], whereas reo-
virus infection has been found to be host-cell specific
[24]. OL-16 is expressed both in L-cells and in RIE-1 cells
that can be infected by reovirus type 1 but not in murine
erythroleukemia (MEL) cells that are resistant to infection
by type 1 reovirus [25]. Forced expression of an OL-16
transgene in MEL cells increases their susceptibility to reo-
virus type 1 infection (J. Sheng and D. Rubin, unpub-
lished results).
Several of the candidate genes have products that interact
with either reovirus or with other viruses (Supplementary
Table [see Additional File 1]). Cellular activities involved
in post-transcriptional gene regulation may influence the
processing or translation of virus transcripts. Two candi-
date genes participate in these processes. Eif3, part of a
multi-subunit translation initiation complex, has been
found to specifically bind the 5' end of hepatitis C and
classical swine fever virus mRNA [26]. The Cstf 64 KaD
subunit, which affects polyadenylation of mRNA, can be
cross-linked to the mRNA of herpes simplex mRNA in
infected HeLa cell extracts [27]. Other candidate genes are
associated with the interferon pathway and host inflam-
matory responses [28-30]. For example, IκBζ (MAIL), as a
component of the NK-κB pathway, may directly or tan-
gentially affect interferon production, inflammation, or
apoptosis. In addition, one gene encodes 6-pyruvoyl-tet-
rahydropterin synthase (Pts), a major regulator of inter-
feron activity [31] associated with inducible nitric oxide
synthase (iNOS). iNOS levels within cells affects the
efficiency of replication of many viruses, including the
avian reoviruses [32,33].
Many of the targeted gene products have roles involving
the Golgi or endosomal compartments (Figure 3), and
additional genes play a role in differentiation or growth
arrest. Of these, several are in the transforming growth fac-
tor (TGF)-β and NF-κB regulatory pathways, Ppm1a [34],
Madh7  [35-37], Ube1c  [38,39], and Map3k7ip1  [40-43]
(Table 1, Supplementary Table [see Additional File 1]). In
addition, subunits of the eif3 complex have been func-
tionally linked to Mapkbp1 and the proteosome [44]. We
have also disrupted a number of genes that participate in
apoptosis (Supplementary Table [see Additional File 1]),
and three disrupted genes affect N-linked protein glyco-
sylation, a process that may affect compartmentalization
of proteins or ligand interactions.
Reovirus resistant cells have altered susceptibility to HSV-1
As several of the genes listed in the Supplementary Table
[see Additional File 1] have been associated with herpes
simplex-1 (HSV-1) replication, seven clones were tested
for their susceptibility to HSV-1 infection [15,45]. These
experiments utilized HSV-1(KOS)tk12, an infectious virus
that expresses a lacZ reporter as an immediate-early gene
[46]. Data representing seven clones with mutations that
tag known genes are provided in Figure 4. Four clones,
with mutations in the Eif3s10, AnxaI, Mgat1, and Igf2r
genes, were resistant to HSV-I infection (Figure 4B,4C, b,
d, f, and h) and there was a diminished capacity to express
the immediate-early lacZ reporter gene. However, two of
the clones (Figure 4B,4C, c and e) with mutations in genes
encoding calcyclin and annexin-II, were more susceptible
than the parental RIE-1 cells to HSV-1 infection and
expressed higher levels of the immediate-early lacZ
reporter gene. Representative clones that contain altered
levels of HSV-1 immediate early gene expression are
shown in Figure 4A. LacZ expression in cells containing a
disrupted calcyclin (S100a6) gene was readily apparent 4
h following infection, whereas lacZ expression was barely
detected in Eif3s10 mutant cells 16h following infection.
In all cases, levels of lacZ expression correlated with sus-
ceptibility to HSV-1 infection, suggesting that resistance
involved early steps in the viral lifecycle.
Discussion
Candidate genes required for lytic reovirus infections were
identified by tagged sequence mutagenesis, a process that
permits rapid identification of genes disrupted by gene
entrapment. Since virus-resistant mutants may arise by a
variety of mechanisms, additional experiments are
needed to demonstrate that individual genes disrupted by
gene entrapment actually contribute to the reovirus-resist-
ant phenotype. Even so, several lines of evidence suggest
that the genes collectively identified by tagged sequence
mutagenesis include cellular activities that participate in
the virus lifecycle. First, reovirus-resistant clones were
selected at higher frequencies from entrapment libraries
than from non-mutagenized cells, suggesting that reovi-
rus-resistant phenotypes were induced by gene trap muta-
genesis. Second, the genes associated with reovirus
resistance differed from genes targeted in an unselected
manner in mouse ES cells. Known mutational hot spots of
the U3NeoSV1 were under-represented, and a number ofBMC Cell Biology 2004, 5:41 http://www.biomedcentral.com/1471-2121/5/41
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HSV-1 infection is affected in cell clones selected as reovirus resistant Figure 4
HSV-1 infection is affected in cell clones selected as reovirus resistant The level of transcription and translation of 
the reporter gene, lacZ, present in the immediate early genes of HSV-1 is shown in A and B. A) The level of expression of 
mRNA is shown at 4, 8 and 16 h following infection for a library of non-reovirus selected RIE-1 cells (L42), and two clones that 
disrupt the Eif3s10 (p162) and S100a6 genes. The cell clone with a disrupted S100a6 gene has a dramatic increase in HSV-1 
expression with a concomitant decrease in cellular gene expression by 16 h. While there is more mRNA loaded in the lane 
with a disrupted Eif3s10 gene than is present in the other lanes, there is no evidence for HSV-1 expression in this cell until 16 
h following infection. B) Translation of the LacZ reporter in the immediate early genes of HSV-1. At 8 hours following infec-
tion, the translation of the LacZ gene is dramatically increased in clones with mutant S100a6 and Anxa2 genes, barely detectable 
in the population of non-selected library cells (L42) and a cell clone that tags the Aptx+/DnaJa1- genes, and is not evident in the 
other mutant clones. C) Cell survival was determined by gentian violet staining of cells at 72 hours. L42 cells, and clones with 
mutations in the Aptx+/DnaJA1, annexin II, and S100a6 genes lysed whereas clones with mutations in the Eif3s10, Anax1, Mgat1, 
and Igfr2 genes were resistant to lytic infection. a-library 42, non-selected; b-Eif3s10; c-calcyclin; d-Anxa1; e-Anxa2; f-Mgat1; g-
Aptx+/DnaJa1 (negative strand); h-Igf2rBMC Cell Biology 2004, 5:41 http://www.biomedcentral.com/1471-2121/5/41
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mutations associated with virus resistance appeared to
cluster within specific cellular processes and/or affected
different components of multi-protein complexes that are
likely to play roles in the virus lifecycle. These include IGF-
II expression/signalling (3 genes), cytoskeletal/vesicular/
trafficking (20 genes), signalling pathways (11 genes),
and apoptosis (4 genes). Finally, we recently demon-
strated that the disruption of Ctcf, a transcriptional repres-
sor of IGF-II, was directly responsible for reovirus-
resistance. In particular, cells containing the Ctcf mutation
express elevated levels IGF-II, while parental RIE1 cells
forced to express IGF-II acquired high levels of reovirus
resistance. The mutation in Ctcf was chosen for further
analysis because it was one of 3 mutations affecting IGF-II
expression and/or signalling [4]. By inference, the recov-
ery of inserts affecting other genes in the IGF-II signalling
pathway suggests that the same phenotype can be
achieved through mutations in multiple genes in a com-
mon pathway. Taken together, these results suggest that
the candidate genes identified by tagged sequence muta-
genesis provide useful information to direct mechanistic
studies of cellular processes that participate in the virus
lifecycle.
These studies utilized a diploid cell line to select for reovi-
rus resistance. Therefore, recessive phenotypes resulting
from loss-of-function mutations are generally expected to
require separate inactivation of genes carried on both
autosomes. In principle this could occur through pre-
existing heterozygosity or by loss of the unoccupied allele
by one of several mechanisms such as gene conversion,
non-disjunction or transcriptional repression. Several of
the candidate genes discovered in these experiments are
imprinted, and therefore may be anticipated to be mono-
allelic in their expression, including the maternally
imprinted Igf2r. Alternatively, mutations induced by gene
entrapment may confer reovirus resistance as a result of
gene dosage effects (e.g. haploinsufficiency). For example,
recent data suggests that the most common genetic dis-
ease in Caucasians, cystic fibrosis, involves mutations in
the ABC-cassette transporter protein, CFTR, that confer
resistance to infection by Salmonella typhi [47]. Protection
is afforded to persons heterozygous at this allele. Simi-
larly, cyclosporin analogs, which affect P glycoprotein (a
member of the ABC cassette transporters), inhibit the
growth of Cryptosporidium parum [48]. Of note, one of the
genes associated with reovirus resistance identified in the
present study, Pgy1  (Abcb1), encodes P glycoprotein
(Table 1, Supplementary Table [see Additional File 1]).
Finally, while the U3NeoSV1 entrapment vector lacks the
MuLV enhancer element, we cannot exclude the possibil-
ity that the phenotype observed was related to dominant
mutations caused either by transcriptional activation of
adjacent cellular genes or from the expression of truncated
proteins with dominant-negative activity.
The circumstances that allow gene entrapment to disrupt
the function of diploid genes illustrate that events second-
ary to provirus integration may be required for expression
of some reovirus resistant phenotypes. Consequently,
while the entrapment libraries were theoretically large
enough (2 × 105 independent mutations) to disrupt all
expressed genes, it seems unlikely that all the genes that
are required for virus infection, and that can be targeted by
tagged sequence mutagenesis, were identified in the
present study.
Reovirus infection may induce apoptosis in vivo and in
vitro, and the suppression of apoptosis enhances the sur-
vival of mice infected with reovirus type 3 [49,50]. Muta-
tions associated with reovirus resistance included a
number in proapototic genes including, IκBζ and Bcl2l1;
however, the precise role of this pathway and the genes we
have disrupted in modulating reovirus infectivity is
unknown [51,52]. Therefore, while many genes are asso-
ciated with known pathways, further studies will be
required to understand the manner by which these path-
ways influence reovirus infection.
Genetic alterations giving rise to reovirus resistant clones
have variable effects on HSV-1 replication, with some reo-
virus resistant clones showing enhanced HSV1 replica-
tion. The reasons for this are unknown, although each of
these two viruses enter cells by different mechanisms. The
early steps in HSV replication require entry into cells,
release of the capsid with migration to the nucleus for
which virus and cellular proteins play roles [53,54],
whereas the entry of reovirus does not involve transit to
the nucleus. Enhanced HSV-1 replication in clones con-
taining mutations in the S100a6 (calcyclin) and Anxa2
genes was accompanied by a dramatic increase in imme-
diate-early gene expression. This temporal enhancement
of HSV-1 replication may reflect activities of calcyclin and
annexin 2 proteins that suppress HSV-1 entry [55-57].
In addition to the clone with a mutation in Anxa1, clones
with mutations in Eif3s10, Mgat1, and Igf2r  also show
decreases in transcription and translation of virus mRNA
and cell death. Of these, mutations in the Igf2r are known
to affect HSV replication [15,54,58]; whereas, association
of HSV replication with proteins encoded by the Eif3s10,
Anxa1, and Mgat1 are novel. These data suggest that some
of the candidate genes discovered in clones surviving
reovirus infection may affect common cellular processes
that are used by other viruses.
Studies in a variety of systems indicate that resistance to
infection may be found in nature or achieved in cultured
cells. Results presented here support the hypothesis that
pathways involved in reovirus infection can be identified
through a functional genomics approach based uponBMC Cell Biology 2004, 5:41 http://www.biomedcentral.com/1471-2121/5/41
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insertional mutagenesis. Systematic selection of virus-
resistant mutant cells in which the mutant gene can be
easily identified may also identify targets for the develop-
ment of anti-viral therapies. Drugs that disrupt cellular
processes may circumvent the problem of virus resistance,
generally observed with drugs against virus-encoded pro-
teins. Moreover, since mutations associated with virus
resistance are, by necessity, not lethal to the cell, drugs
that target the same processes are not expected to have
overtly toxic side effects. The fact that the resulting candi-
date genes may play roles in the replication of other
viruses, suggests that different viruses may use similar host
proteins for common steps required for virus entry, disas-
sembly, transcription, translation, and reassembly. This
view is supported by our studies with HSV-1 and by pub-
lished reports implicating several of the genes disrupted in
reovirus resistant cells (Supplementary Table [see Addi-
tional File 1]) in the replication of other viruses. Thus,
mutant clones selected for resistance to lytic infection to
one virus may provide targets for therapeutics that are
active against other families of viruses.
The dramatic increase in the pace of the genome project
has led to an explosion of information concerning the
sequence of the genome of several species of animals and
pathogenic organisms. However, most of the gene
sequences have not been functionally ascribed with regard
to host-parasite interactions. As there are approximately
30 to 50 × 103 mammalian genes, the definition of func-
tion will become the major task facing scientists interested
in the relationship between host genes and viral disease
over the next decade.
Conclusions
Candidate host genes that participate in lytic virus infec-
tions were identified utilizing insertional mutagenesis.
Mutant cell clones were recovered that lost their capacity
to support virus replication, but were able to proliferate.
There was enrichment for genes that were involved in par-
ticular metabolic or signalling pathways, with many of the
genes being selected more than once from independently
derived libraries of RIE-1 cells. Several of the gene prod-
ucts are known to bind to each other. These genes or their
products, which are identified by this process of selection,
may provide targets for therapeutic intervention.
Methods
RIE-1, L-Cells and Virus
Reovirus type 1, strain Lang, was initially obtained from
Bernard N. Fields. Virus was passaged in L-cells and a third
passaged stock was purified over a CsCl gradient as previ-
ously described and was used for these experiments [59].
To develop PI cell lines, RIE-1 cells were infected with reo-
virus type 1, at a multiplicity of infection (MOI) of 5, and
surviving cells were maintained in Dulbecco's
modification of Eagle's minimum essential medium
(DMEM) (Irvine Scientific, Santa Ana, CA, USA). The her-
pes simplex virus (HSV)-1 clone, HSV-1 KOStk12, that
expresses a reporter gene, lacZ, as an immediate-early gene
[46] was a generous gift of Patricia Spear, Northwestern
University, USA. For RIE-1 and L-cells, medium was sup-
plemented with 10% fetal bovine serum, 2 mM per ml, L-
Glutamine 100 units per ml, Penicillin, and 100 µg per ml
Streptomycin (Irvine Scientific, Santa Ana, CA, USA)
[complete medium]. In some experiments, serum was
omitted from the medium. The continuance of cell mon-
olayers following infection with reovirus or HSV-1 was
determined by staining with gentian violet.
Tagged sequence mutagenesis and selection for reovirus 
resistance
Following infection of RIE-1 cells with the U3neoSV1 vec-
tor, MOI of 0.1, mutagenized cells were selected for neo-
mycin resistance in medium containing 1 mg/ml G418
sulfate (Clontech, Palo Alto, CA, USA) [6]. Twenty librar-
ies of mutant RIE-1 cells, and one library of A549 human
adenocarcinoma cells, each consisting of 104 gene entrap-
ment events, were expanded until approximately 103 sib-
ling cells represented each mutant clone. These cells were
plated at a sub-confluent density and incubated in serum-
free media for 3 days until they became quiescent, and
infected with reovirus serotype 1, MOI of 35 plaque form-
ing units (pfu) per cell. Eighteen hours following infec-
tion, the cells were detached with trypsin, and plated in
DMEM medium containing 10% fetal bovine serum (FBS)
(Hyclone Laboratories, Inc., Logan, Utah, USA). After 6
hrs, the medium was removed and cells were maintained
in serum-free medium until only a few cells remained
attached to the flask. On average, one to ten clones were
recovered from a library consisting of 107 mutant cells, an
enrichment for selected cells of six orders of magnitude.
Cells that survived the selection were transferred to cell
culture plates in media containing 10% FBS and cells were
divided for extraction of DNA and cryopreservation.
Transcription and translation of HSV-1 immediate early 
gene reporter
The transcription and translation of the HSV-1 immediate
early gene reporter gene, lacZ, was determined by standard
northern blot techniques and β-galactosidase assay,
respectively.
Generation of libraries of mutagenized RIE-1 cells
Libraries of mutagenized cells were infected with reovirus
serotype-1, strain Lang, to select for clones resistant to
lytic infection. Selection of virus-resistant clones was per-
formed in serum-free medium to suppress the emergence
of persistently infected (PI) cells [4]. This is important
since PI cells, which arise by a process involving adaptive
mutations in both the virus and the cell genomes [60],BMC Cell Biology 2004, 5:41 http://www.biomedcentral.com/1471-2121/5/41
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provide a means whereby RIE-1 cells can acquire virus
resistance in the absence of cellular mutations. Uninfected
RIE-1 cells undergo growth arrest, whereas PI RIE-1 cells
are killed in serum-free medium.
DNA sequence analysis
Genomic DNA immediately adjoining the 5' end of the
proviral insert in each of 130 cell lines was cloned by plas-
mid rescue [6]. Approximately 300 to 600 base pairs of
this flanking DNA were sequenced and compared with the
non-redundant (nr) and expressed sequence tag (dbEST)
nucleic acid databases [61]. The probability of a match
with orthologous sequences in the databases varies due to
interspecies variation, the amount of exon in the flanking
DNA (in cases where the flanking DNA matches cDNA
sequences), alternative splicing and sequencing errors.
Matches with sequences in the database were considered
potentially significant if probability score was <10-5 and
the sequence was non-repetitive. In most cases, the match-
ing gene was in the same transcriptional orientation as the
provirus. Moreover, matches involving cDNA sequences
were co-linear across exons present in the flanking
genomic DNA and diverged at splice sites. As indicated,
virtually all of the genes identified had matches to murine,
rat, or human gene sequences with p < 10-10.
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